{"id":"https://openalex.org/W2038469874","doi":"https://doi.org/10.1182/blood-2005-01-0333","title":"Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling","display_name":"Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling","alternate_titles":[],"publication_year":2005,"publication_date":"2005-07-22","ids":{"openalex":"https://openalex.org/W2038469874","doi":"https://doi.org/10.1182/blood-2005-01-0333","mag":"2038469874","pmid":"https://pubmed.ncbi.nlm.nih.gov/16037392"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2005-01-0333","doi":"https://doi.org/10.1182/blood-2005-01-0333","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2005-01-0333","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2038469874"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078170168","display_name":"Nisha Nanda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210094896","display_name":"Portola Pharmaceuticals (United States)","ror":"https://ror.org/00r8a6s58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094896"]},{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nisha Nanda","raw_affiliation_strings":["From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","Millennium Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210094896","https://openalex.org/I4405270001"]},{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","institution_ids":["https://openalex.org/I4210094896"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112870166","display_name":"Patrick Andr\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210094896","display_name":"Portola Pharmaceuticals (United States)","ror":"https://ror.org/00r8a6s58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094896"]},{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrick Andre","raw_affiliation_strings":["From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","Millennium Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210094896","https://openalex.org/I4405270001"]},{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","institution_ids":["https://openalex.org/I4210094896"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113738583","display_name":"Ming Bao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210094896","display_name":"Portola Pharmaceuticals (United States)","ror":"https://ror.org/00r8a6s58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094896"]},{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ming Bao","raw_affiliation_strings":["From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","Millennium Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210094896","https://openalex.org/I4405270001"]},{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","institution_ids":["https://openalex.org/I4210094896"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006801972","display_name":"Karl R. Clauser","orcid":"https://orcid.org/0000-0002-1052-9456","observed_orcids":["https://orcid.org/0000-0002-1052-9456"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210094896","display_name":"Portola Pharmaceuticals (United States)","ror":"https://ror.org/00r8a6s58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094896"]},{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Karl Clauser","raw_affiliation_strings":["From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","Millennium Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210094896","https://openalex.org/I4405270001"]},{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","institution_ids":["https://openalex.org/I4210094896"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020860588","display_name":"Francis R. DeGuzman","orcid":"https://orcid.org/0000-0002-4479-1129","observed_orcids":["https://orcid.org/0000-0002-4479-1129"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210094896","display_name":"Portola Pharmaceuticals (United States)","ror":"https://ror.org/00r8a6s58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094896"]},{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francis Deguzman","raw_affiliation_strings":["From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","Millennium Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210094896","https://openalex.org/I4405270001"]},{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","institution_ids":["https://openalex.org/I4210094896"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036047725","display_name":"Duncan Howie","orcid":"https://orcid.org/0000-0003-0043-3546","observed_orcids":["https://orcid.org/0000-0003-0043-3546"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210094896","display_name":"Portola Pharmaceuticals (United States)","ror":"https://ror.org/00r8a6s58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094896"]},{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Duncan Howie","raw_affiliation_strings":["From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","Millennium Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210094896","https://openalex.org/I4405270001"]},{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","institution_ids":["https://openalex.org/I4210094896"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054604221","display_name":"Pamela B. Conley","orcid":"https://orcid.org/0000-0001-9400-6531","observed_orcids":["https://orcid.org/0000-0001-9400-6531"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210094896","display_name":"Portola Pharmaceuticals (United States)","ror":"https://ror.org/00r8a6s58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094896"]},{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pamela B. Conley","raw_affiliation_strings":["From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","Millennium Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210094896","https://openalex.org/I4405270001"]},{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","institution_ids":["https://openalex.org/I4210094896"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013948185","display_name":"Cox Terhorst","orcid":"https://orcid.org/0000-0001-6233-7029","observed_orcids":["https://orcid.org/0000-0001-6233-7029","https://orcid.org/0000-0002-4545-663X"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210094896","display_name":"Portola Pharmaceuticals (United States)","ror":"https://ror.org/00r8a6s58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094896"]},{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cox Terhorst","raw_affiliation_strings":["From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","Millennium Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210094896","https://openalex.org/I4405270001"]},{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","institution_ids":["https://openalex.org/I4210094896"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040378209","display_name":"David R. Phillips","orcid":"https://orcid.org/0000-0002-0998-5403","observed_orcids":["https://orcid.org/0000-0002-0998-5403"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210094896","display_name":"Portola Pharmaceuticals (United States)","ror":"https://ror.org/00r8a6s58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094896"]},{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David R. Phillips","raw_affiliation_strings":["From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","Millennium Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA; the Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210094896","https://openalex.org/I4405270001"]},{"raw_affiliation_string":"From Portola Pharmaceuticals and Millennium Pharmaceuticals, San Francisco, CA","institution_ids":["https://openalex.org/I4210094896"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270001"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":6.9087,"has_fulltext":false,"cited_by_count":120,"citation_normalized_percentile":{"value":0.9740417,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"106","issue":"9","first_page":"3028","last_page":"3034"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":1.0},{"id":"https://openalex.org/keywords/slam-family-receptors","display_name":"SLAM family receptors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/cd84","display_name":"CD84","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cd150","display_name":"CD150","score":0.996999979019165},{"id":"https://openalex.org/keywords/eat-2","display_name":"EAT-2","score":0.9779999852180481},{"id":"https://openalex.org/keywords/tyrosine-phosphorylation","display_name":"tyrosine phosphorylation","score":0.9890000224113464},{"id":"https://openalex.org/keywords/platelet-signaling","display_name":"platelet signaling","score":0.675000011920929},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.8009999990463257},{"id":"https://openalex.org/keywords/arterial-thrombosis","display_name":"arterial thrombosis","score":0.9359999895095825},{"id":"https://openalex.org/keywords/platelet-spreading","display_name":"platelet spreading","score":0.7080000042915344}],"concepts":[{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.76462721824646},{"id":"https://openalex.org/C3018697912","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Platelet activation","level":3,"score":0.764275312423706},{"id":"https://openalex.org/C2777553839","wikidata":"https://www.wikidata.org/wiki/Q14330986","display_name":"Tyrosine phosphorylation","level":3,"score":0.6606326103210449},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.6312342882156372},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6286699175834656},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.5481597781181335},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.5015592575073242},{"id":"https://openalex.org/C2780009322","wikidata":"https://www.wikidata.org/wiki/Q7202246","display_name":"Platelet adhesiveness","level":4,"score":0.46724462509155273},{"id":"https://openalex.org/C150555746","wikidata":"https://www.wikidata.org/wiki/Q210973","display_name":"Cell signaling","level":3,"score":0.4624064266681671},{"id":"https://openalex.org/C2910542480","wikidata":"https://www.wikidata.org/wiki/Q2335787","display_name":"Platelet Glycoprotein GPIIb-IIIa Complex","level":4,"score":0.41842421889305115},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.34551382064819336},{"id":"https://openalex.org/C2993802102","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet aggregation","level":3,"score":0.24371430277824402},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22630271315574646},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17567822337150574}],"mesh":[{"descriptor_ui":"D000071176","descriptor_name":"Signaling Lymphocytic Activation Molecule Family","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000071177","descriptor_name":"Signaling Lymphocytic Activation Molecule Family Member 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":false},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D011956","descriptor_name":"Receptors, Cell Surface","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019000","descriptor_name":"Phosphotyrosine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D048868","descriptor_name":"Adaptor Proteins, Signal Transducing","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood-2005-01-0333","doi":"https://doi.org/10.1182/blood-2005-01-0333","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2005-01-0333","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:16037392","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16037392","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5683000087738037,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1493547476","https://openalex.org/W1539185722","https://openalex.org/W1567696770","https://openalex.org/W1966226088","https://openalex.org/W1968204784","https://openalex.org/W1985278107","https://openalex.org/W1985618257","https://openalex.org/W1990617987","https://openalex.org/W1997712588","https://openalex.org/W2022851623","https://openalex.org/W2032242135","https://openalex.org/W2038232273","https://openalex.org/W2043152943","https://openalex.org/W2054540030","https://openalex.org/W2061965077","https://openalex.org/W2072584472","https://openalex.org/W2074707530","https://openalex.org/W2087305090","https://openalex.org/W2117690348","https://openalex.org/W2136589340","https://openalex.org/W2137108685","https://openalex.org/W2138007390","https://openalex.org/W2139972785","https://openalex.org/W2146182770","https://openalex.org/W2162436188"],"related_works":["https://openalex.org/W1978375825","https://openalex.org/W7095624465","https://openalex.org/W2245742486","https://openalex.org/W2062045566","https://openalex.org/W1974381086","https://openalex.org/W2333994201","https://openalex.org/W2120643517","https://openalex.org/W3128019026","https://openalex.org/W2018169527"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2038469874","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
